SYBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Stock Yards Bancorp Inc (SYBT) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading near resistance, sentiment is constructive but not compelling enough, and there is no clear catalyst or strong proprietary buy signal. My direct view: hold and wait for a better entry rather than buying immediately.
SYBT is in a bullish intermediate trend: MACD histogram is positive and expanding, and the moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). However, RSI_6 is elevated at 78.241, showing the stock is stretched after the recent move. Price at 78.11 is right near R1 resistance at 78.108, which makes the current level less attractive for a fresh long-term entry. The pattern-based trend estimate is also constructive, with a modeled 80% chance of a 1.29% move next day, 2.45% next week, and 15.01% next month, but this does not outweigh the near-term resistance setup.
["Insiders are buying, with buying activity up 1802.22% over the last month, which is a meaningful positive signal.", "Analyst price targets have been nudged higher across multiple firms, including Piper Sandler raising target to $81 and Keefe Bruyette also at $81.", "Technical trend remains bullish with SMA alignment and expanding positive MACD.", "No recent negative news and no adverse event-driven headlines in the last week."]
["There is no AI Stock Picker signal today.", "There is no SwingMax signal recently.", "Price is sitting right at resistance near 78.11, limiting immediate upside from a new entry.", "RSI is elevated, indicating the stock is already extended.", "Hedge funds are neutral with no significant trading trends over the last quarter.", "No recent news catalysts and no congress trading activity to support a fresh momentum case."]
No usable latest-quarter financial snapshot was provided because of a data error, so I cannot confirm recent revenue, earnings, or margin growth from the latest quarter season. Based on the available data alone, there is not enough financial evidence here to justify an aggressive long-term buy.
Analyst sentiment is mostly Neutral/Equal Weight. Recent price targets have trended modestly upward: Piper Sandler raised its target to $81 from $78 and Keefe Bruyette is at $81, while Stephens raised target to $70 from $67. The overall Wall Street view is balanced rather than bullish: pros see improving estimates and valuation support, but the ratings remain Neutral/Market Perform/Equal Weight, which means analysts do not see major upside from current levels.
